The Clorox Company (NYSE:CLX) Shares Purchased by Sanctuary Advisors LLC

Sanctuary Advisors LLC boosted its holdings in The Clorox Company (NYSE:CLXFree Report) by 5.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,292 shares of the company’s stock after purchasing an additional 1,190 shares during the quarter. Sanctuary Advisors LLC’s holdings in Clorox were worth $3,737,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. WBH Advisory Inc. boosted its holdings in Clorox by 12.9% in the fourth quarter. WBH Advisory Inc. now owns 1,522 shares of the company’s stock valued at $247,000 after purchasing an additional 174 shares in the last quarter. Strategic Financial Concepts LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $3,428,000. Allworth Financial LP boosted its holdings in shares of Clorox by 3.0% in the fourth quarter. Allworth Financial LP now owns 7,583 shares of the company’s stock valued at $1,204,000 after acquiring an additional 219 shares during the period. Everhart Financial Group Inc. boosted its holdings in shares of Clorox by 25.9% in the fourth quarter. Everhart Financial Group Inc. now owns 2,555 shares of the company’s stock valued at $415,000 after acquiring an additional 526 shares during the period. Finally, Blue Trust Inc. boosted its holdings in shares of Clorox by 36.8% in the fourth quarter. Blue Trust Inc. now owns 1,249 shares of the company’s stock valued at $203,000 after acquiring an additional 336 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Wells Fargo & Company increased their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. DA Davidson decreased their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. JPMorgan Chase & Co. increased their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $158.21.

Get Our Latest Analysis on Clorox

Clorox Trading Up 2.8 %

NYSE:CLX opened at $157.41 on Friday. The stock has a fifty day moving average price of $157.87 and a two-hundred day moving average price of $159.63. The stock has a market capitalization of $19.39 billion, a price-to-earnings ratio of 43.01, a PEG ratio of 2.58 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the business earned $2.16 earnings per share. As a group, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.